163 related articles for article (PubMed ID: 26967741)
1. Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse Model.
Liu C; Janke LJ; Kawedia JD; Ramsey LB; Cai X; Mattano LA; Boyd KL; Funk AJ; Relling MV
PLoS One; 2016; 11(3):e0151433. PubMed ID: 26967741
[TBL] [Abstract][Full Text] [Related]
2. A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday.
Yang L; Boyd K; Kaste SC; Kamdem Kamdem L; Rahija RJ; Relling MV
J Orthop Res; 2009 Feb; 27(2):169-75. PubMed ID: 18683891
[TBL] [Abstract][Full Text] [Related]
3. Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models.
Karol SE; Janke LJ; Panetta JC; Ramsey LB; Cai X; Payton MA; Jenkins DA; Evans WE; Relling MV
PLoS One; 2019; 14(5):e0216328. PubMed ID: 31059548
[TBL] [Abstract][Full Text] [Related]
4. Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis.
Janke LJ; Liu C; Vogel P; Kawedia J; Boyd KL; Funk AJ; Relling MV
Am J Pathol; 2013 Jul; 183(1):19-25. PubMed ID: 23673001
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.
Finch ER; Janke LJ; Smith CA; Karol SE; Pei D; Cheng C; Kaste SC; Inaba H; Pui CH; Wolf J; Relling MV
Pediatr Blood Cancer; 2019 Jun; 66(6):e27669. PubMed ID: 30758124
[TBL] [Abstract][Full Text] [Related]
6. Substrain-specific differences in survival and osteonecrosis incidence in a mouse model.
Kawedia JD; Janke L; Funk AJ; Ramsey LB; Liu C; Jenkins D; Boyd KL; Relling MV
Comp Med; 2012 Dec; 62(6):466-71. PubMed ID: 23561879
[TBL] [Abstract][Full Text] [Related]
7. Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis.
He M; Wang J; Wang G; Tian Y; Jiang L; Ren Z; Qiu C; Fu Q
Mol Med Rep; 2016 Aug; 14(2):1054-60. PubMed ID: 27277157
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin II combined with asparaginase and dexamethasone on the femoral head in mice: A model of steroid-induced femoral head osteonecrosis.
Liu J; Li C; Yang F; Li M; Wu B; Chen H; Li S; Zhang X; Yang J; Xia Y; Wu M; Li Y; Liu B; Zhao D
Front Cell Dev Biol; 2022; 10():975879. PubMed ID: 36187471
[No Abstract] [Full Text] [Related]
9. Effect of premedications in a murine model of asparaginase hypersensitivity.
Fernandez CA; Smith C; Karol SE; Ramsey LB; Liu C; Pui CH; Jeha S; Evans WE; Finkelman FD; Relling MV
J Pharmacol Exp Ther; 2015 Mar; 352(3):541-51. PubMed ID: 25573198
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-induced osteonecrosis.
Weinstein RS
Endocrine; 2012 Apr; 41(2):183-90. PubMed ID: 22169965
[TBL] [Abstract][Full Text] [Related]
11. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia.
Yang L; Panetta JC; Cai X; Yang W; Pei D; Cheng C; Kornegay N; Pui CH; Relling MV
J Clin Oncol; 2008 Apr; 26(12):1932-9. PubMed ID: 18421047
[TBL] [Abstract][Full Text] [Related]
12. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
te Winkel ML; Appel IM; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2008 Oct; 93(10):1570-4. PubMed ID: 18698082
[TBL] [Abstract][Full Text] [Related]
13. Genetics of pleiotropic effects of dexamethasone.
Ramsey LB; Pounds S; Cheng C; Cao X; Yang W; Smith C; Karol SE; Liu C; Panetta JC; Inaba H; Rubnitz JE; Metzger ML; Ribeiro RC; Sandlund JT; Jeha S; Pui CH; Evans WE; Relling MV
Pharmacogenet Genomics; 2017 Aug; 27(8):294-302. PubMed ID: 28628558
[TBL] [Abstract][Full Text] [Related]
14. Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD).
Hui L; Wiernik PH
Am J Hematol; 1996 Jul; 52(3):184-8. PubMed ID: 8756084
[TBL] [Abstract][Full Text] [Related]
15. Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice.
Kikuiri T; Kim I; Yamaza T; Akiyama K; Zhang Q; Li Y; Chen C; Chen W; Wang S; Le AD; Shi S
J Bone Miner Res; 2010 Jul; 25(7):1668-79. PubMed ID: 20200952
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the effects of asparaginase from Escherichia coli and a glutaminase-free asparaginase from Vibrio succinogenes on specific ell-mediated cytotoxicity.
Durden DL; Distasio JA
Int J Cancer; 1981 Jan; 27(1):59-65. PubMed ID: 7019106
[No Abstract] [Full Text] [Related]
17. Effect of L-asparaginase on retention of maze learning in mice.
Hooghe-Peters EL
Life Sci; 1973 Aug; 13(3):185-90. PubMed ID: 4584420
[No Abstract] [Full Text] [Related]
18. Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice.
Finch ER; Payton MA; Jenkins DA; Cai X; Li L; Karol SE; Relling MV; Janke LJ
Haematologica; 2021 Aug; 106(8):2095-2101. PubMed ID: 32675219
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Mattano LA; Sather HN; Trigg ME; Nachman JB
J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
[TBL] [Abstract][Full Text] [Related]
20. Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumour-bearing mice.
Bendich A; Kafkewitz D; Abuchowski A; Davis FF
Clin Exp Immunol; 1982 Apr; 48(1):273-8. PubMed ID: 7044632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
